TAE TAO p Age (years) 78.76 ± 7.14 79.72 ± 7.32 0.52 Female (%) 65.15 76.47 0.28 Right eye (%) 48.83 44.11 0.68 Pseudophakia (%) 60.9 48.48 0.28 Glaucoma (%) 12.5 17.6 0.53 Type of CNVM (FA) (%)       Classic 18.18 28.57 0.83 Min. Classic 9.09 7.14 Occult 72.73 64.29 Location of CNVM (FA) (%)       Subfoveal 75 75 0.80 Juxtafoveal 0 8.33 Extrafoveal 25 16.67 IOP (mmHg) 15.58 ± 3.26 16.35 ± 3.25 0.36 BCVA LogMar (Snellen) 0.73 (20/107) ± 0.23 0.85 (20/141) ± 0.30 0.10 CRT (µm) 318.27 ± 95.22 308.95 ± 87.43 0.70 N 30 30   P<0.05 was considered statistically significant (in bold print)

Table 1: Demographic and Clinical Characteristics of Both Study Groups at Baseline. TAE: Treat and Extend; TAO: Treat and Observe; FA: Fluorescein Angiogram; IOP: Intraocular Pressure; BCVA: Best Corrected Visual Acuity; LogMAR: Logarithm of the Minimum Angle of Resolution; CRT: Central Retinal Thickness; N: Number of subjects.